FATE
Price
$1.33
Change
-$0.04 (-2.92%)
Updated
Apr 23 closing price
Capitalization
157.01M
6 days until earnings call
SNSE
Price
$0.37
Change
+$0.02 (+5.71%)
Updated
Apr 23 closing price
Capitalization
8.73M
19 days until earnings call
Ad is loading...

FATE vs SNSE

Header iconFATE vs SNSE Comparison
Open Charts FATE vs SNSEBanner chart's image
Fate Therapeutics
Price$1.33
Change-$0.04 (-2.92%)
Volume$2.16M
Capitalization157.01M
Sensei Biotherapeutics
Price$0.37
Change+$0.02 (+5.71%)
Volume$149.8K
Capitalization8.73M
FATE vs SNSE Comparison Chart
Loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FATE vs. SNSE commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Hold and SNSE is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (FATE: $1.34 vs. SNSE: $0.37)
Brand notoriety: FATE and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 81% vs. SNSE: 4%
Market capitalization -- FATE: $157.01M vs. SNSE: $8.73M
FATE [@Biotechnology] is valued at $157.01M. SNSE’s [@Biotechnology] market capitalization is $8.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, FATE is a better buy in the long-term than SNSE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 5 TA indicator(s) are bullish while SNSE’s TA Score has 5 bullish TA indicator(s).

  • FATE’s TA Score: 5 bullish, 5 bearish.
  • SNSE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SNSE is a better buy in the short-term than FATE.

Price Growth

FATE (@Biotechnology) experienced а +27.14% price change this week, while SNSE (@Biotechnology) price change was -11.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

FATE is expected to report earnings on Jul 30, 2025.

SNSE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($157M) has a higher market cap than SNSE($8.73M). FATE YTD gains are higher at: -19.091 vs. SNSE (-24.485). SNSE has higher annual earnings (EBITDA): -28.38M vs. FATE (-176.58M). FATE has more cash in the bank: 279M vs. SNSE (47M). SNSE has less debt than FATE: SNSE (4.47M) vs FATE (85.3M). FATE has higher revenues than SNSE: FATE (13.6M) vs SNSE (0).
FATESNSEFATE / SNSE
Capitalization157M8.73M1,799%
EBITDA-176.58M-28.38M622%
Gain YTD-19.091-24.48578%
P/E RatioN/AN/A-
Revenue13.6M0-
Total Cash279M47M594%
Total Debt85.3M4.47M1,909%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FATESNSE
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 10 days ago
74%
Declines
ODDS (%)
Bearish Trend 24 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCVTX16.33N/A
N/A
Fidelity Advisor Small Cap Value M
GRHIX12.53N/A
N/A
Goehring & Rozencwajg Resources Instl
CVMRX17.46N/A
N/A
Calvert Emerging Markets Equity R6
VDMCX9.13N/A
N/A
Virtus KAR Developing Markets C
HFLGX10.48N/A
N/A
Hennessy Cornerstone Large Growth Inv

FATE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with ALLO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
-2.55%
ALLO - FATE
55%
Loosely correlated
+1.26%
NTLA - FATE
55%
Loosely correlated
-2.65%
CRBU - FATE
52%
Loosely correlated
+0.79%
CRSP - FATE
50%
Loosely correlated
-1.76%
RXRX - FATE
48%
Loosely correlated
-0.89%
More

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
+6.90%
VSTM - SNSE
45%
Loosely correlated
+1.14%
ALZN - SNSE
40%
Loosely correlated
N/A
GRI - SNSE
38%
Loosely correlated
+25.52%
FATE - SNSE
36%
Loosely correlated
-2.55%
INAB - SNSE
33%
Loosely correlated
+5.39%
More